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Modern cardiology owes much of its success and identity to
a long series of spectacular technological advances and
procedural innovations. Beginning more than a century ago,
technology not only revolutionized the way doctors evalu-
ated their patients, but it also transformed the way patients
viewed their doctors. Specialists began to be identified, in
part, by the equipment they used and the tests and proce-
dures they performed. Our contemporary enthusiasm for
medical technology, despite its cost and complexity, reflects
the conviction that it contributes significantly to the diag-
nosis and treatment of cardiovascular disease.
Earlier generations of doctors and patients embraced the
technologies of their time, and they shared our fascination
with new diagnostic tools and techniques. The discovery of
X-rays in 1895 and the invention of the electrocardiograph
(ECG) seven years later heralded a new era in medical
practice that saw instruments of precision, machines, and
procedures replace the physician’s unaided senses and the
stethoscope as the primary tools of cardiac diagnosis. This
trend continues today because physicians and patients alike
value objective and accurate analysis of the heart’s structure
and function.
Modern medical technology is fantastically fertile. So-
phisticated machines generate incredible images and moun-
tains of data. Contemporary technology is so powerful and
seductive that it has claimed center stage in cardiovascular
care. A decade ago British cardiologist John Goodwin
wrote, “The appeal of technological investigation is irresist-
ible. The young cardiologist, vibrating with passionate
desire to analyze the instrumental results, cannot always see
the point of laborious clinical examination” (1). Finances, of
course, help fuel our infatuation with technology.
TECHNOLOGY TRANSFORMS DIAGNOSIS
Powerful economic forces catalyze the multifactorial equa-
tion that defines the search for—and eventual application
of—new tools and techniques to help diagnose illness and
treat patients. The ultimate goal of all this creative energy is
to help men, women, and children with cardiovascular
disease. During the past century, the pace of discovery,
invention, and innovation in medicine has accelerated dra-
matically. A combination of altruism and entrepreneurial-
ism ignited the creativity that culminated in countless
practical advances. This phenomenon is apparent if one
looks back even further—to 1816—when the French phy-
sician and pathologist Rene´ Laennec invented the stetho-
scope. Three years later he publicized the unique value of his
invention in a two-volume monograph. Laennec also man-
ufactured and sold the earliest stethoscopes, which were
simple cylindrical tubes made of wood. One end of the
instrument was placed on the patient’s chest, while the other
end was applied to the examiner’s ear.
In retrospect, the stethoscope was more than a simple
tool to help doctors listen to sounds coming from the heart
and lungs. Although Laennec and other early advocates of
auscultation could not appreciate it, the simple instrument
transformed the way doctors searched for disease. In a
figurative sense the stethoscope transported physicians seek-
ing a cardiac or pulmonary diagnosis inside their patients. It
also signaled the transformation of medical diagnosis from a
passive process—whereby physicians listened to their pa-
tients’ complaints, palpated the pulse, and looked at their
body and urine—into an active process, whereby doctors
used all sorts of instruments and machines to aid their
senses. During the middle third of the nineteenth century,
a multitude of “scopes” were invented to probe other organs
and orifices, both figuratively and literally.
In 1895, the concept of “looking” inside a patient
changed forever. When German physicist Wilhelm Ro¨nt-
gen discovered X-rays that year, he gave physicians a
powerful technique that made the skin transparent and the
bones and internal organs visible. In terms of cardiology,
this dramatic scientific discovery also meant that doctors
could measure the heart’s size and watch it move (once the
fluoroscope was invented in 1896). As useful as the X-ray
was for studying the heart and lungs, it was not focused on
any specific organ. The ECG, by contrast, was an invention
that not only targeted a single organ; it catalyzed the
creation of a clinical specialty: cardiology.
The 1902 invention of the ECG by Dutch physiologist
Willem Einthoven gave physicians a powerful tool to help
them diagnose various forms of heart disease (2). Like
Laennec’s stethoscope and Ro¨ntgen’s X-rays, Einthoven’s
ECG spoke for itself. Each of these innovations provided
unique information that promised to unlock a few more of
the heart’s secrets. The ECG’s unique value in identifying
and characterizing cardiac arrhythmias was apparent imme-
diately. Physicians and researchers interested in heart dis-
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ease and cardiac physiology used the instrument to study
disorders of the heartbeat.
Gradually, it became apparent that the ECG’s value was
not limited to cardiac arrhythmias. In 1919, James Herrick,
a Chicago physician who had described the clinical syn-
drome of acute myocardial infarction (AMI) nine years
earlier, reported distinctive T-wave changes on the ECG
that accompanied coronary thrombosis. This discovery
stimulated even more interest in the ECG as a clinical tool
and greatly enhanced the physician’s ability to recognize
AMI.
Reflecting on “the development of the science of diagno-
sis,” Johns Hopkins internist Lewellys Barker declared in
1917, “A physician that went to sleep in 1890 and woke up
yesterday would find himself a disoriented Rip Van Winkle
in diagnosis, with utterly antiquated ideas and information.
The diagnostician that sleeps longer than eight or nine
hours at a stretch in these days runs a risk!”(3). Barker’s Rip
Van Winkle would have slept through the discovery of
X-rays, the invention of the ECG, the introduction of the
sphygmomanometer, and the development of a multitude of
serological and laboratory tests.
THE INVENTION OF CARDIOLOGY
America’s first practitioner cardiologist, Louis F. Bishop of
New York City, was wide awake during this dynamic era of
medical discovery and invention. During the second decade
of the 20th century, he incorporated several recent techno-
logical advances into his growing cardiology practice.
Meanwhile, his decision to equip his private office with an
ECG machine, X-ray apparatus, and pulse-recording
equipment reinforced his identity as a heart specialist. So,
technology not only helped Bishop define the scope of his
practice, but it also made it easier for his peers and patients
to see that he was a specific type of doctor—a cardiologist.
Cardiology was then a totally new specialty that Bishop and
a few other American and European physicians were defin-
ing. A specialty framed, to a significant degree, in terms of
technology. In 1922, Bishop advocated the routine use of
the ECG machine, X-ray, and fluoroscope as part of a
“complete cardiological examination of every patient” with
known or suspected heart disease (4).
The first-generation cardiologists in the U.S. and Europe
(who invented the specialty between the World Wars) relied
on the stethoscope, sphygmomanometer, ECG machine,
chest X-ray, and fluoroscope to help them evaluate and
manage heart patients. Several of the tools and technologies
they used were enhanced from a functional standpoint
during the 1930s. For example, that was when the clinical
value of precordial ECG leads was described and truly
portable ECG machines were invented. There were no
major technological “breakthroughs” to rival the discovery of
X-rays or the invention of the ECG, however. The next
major wave of technological and procedural innovation that
transformed cardiology practice owed much to discoveries
and inventions that were unanticipated byproducts of mil-
itary research.
The pace of medical invention and innovation in the U.S.
accelerated dramatically after World War II, when the
federal government began to spend millions (and eventually
billions) of dollars on research. Meanwhile, the field of
biomedical engineering emerged, and many private compa-
nies were formed around the world to adapt technological
advances such as the transistor and the computer for use in
diagnosis and treatment. Cardiology, as much as any spe-
cialty, has benefited from the tremendous technological
advances of the past half-century. There isn’t enough space
here even to list all the new procedures and equipment that
resulted from a frenzy of public and private research and
development.
THE CARDIAC CATHETER AS A CLINICIAN’S TOOL
Just as the ECG helped define and develop cardiology
during the first half of the 20th century, the cardiac catheter
catalyzed the specialty during the second half of the century.
In 1929, German surgical resident Werner Forssmann
published the results of his self-experiment that demon-
strated right heart catheterization was possible and safe in
humans. Soon, several radiologists, physiologists, and phy-
sicians in Europe and the Americas adapted the cardiac
catheter to help them answer various clinical and research
questions. For example, angiocardiography, invented in the
1930s, used the catheter as a conduit for the injection of
contrast material to visualize the cardiac chambers and
identify intracardiac shunts.
In 1941, Andre´ Cournand and his colleagues in New
York City published the first of a series of papers that
demonstrated the value of the cardiac catheter as a tool for
studying cardiopulmonary physiology in humans. Shortly
thereafter, two things helped transform cardiac catheteriza-
tion from a physiologist’s research tool into a clinical
cardiologist’s diagnostic technique: 1) concern about the
physiology and treatment of shock during World War II
and 2) the invention of the Blalock-Taussig “blue baby”
operation in 1944. Dramatic advances in cardiac surgery
during the 1950s, especially the invention of open-heart
surgery using the heart–lung machine, stimulated the cre-
ation of hundreds of cardiac catheterization laboratories in
academic medical centers and referral hospitals in the U.S.
The invention of selective coronary angiography by Ma-
son Sones in 1958 had an extraordinary effect on cardiology
and cardiac surgery. This technique was based on a combi-
nation of procedural innovations and technological devel-
opments dating back to the discovery of X-rays in 1895.
When Sone’s surgical colleague Rene´ Favaloro reported his
early experience with saphenous vein coronary artery bypass
surgery for angina pectoris in 1968 and 1969, he empha-
sized that coronary angiography was an indispensable part
of patient selection. It also provided surgeons with a road
map to help them plan their operation. During the 1970s,
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demand for cardiologists trained to perform coronary an-
giography grew dramatically, and the procedure diffused
rapidly.
The many technological and procedural advances that
were critical for the introduction of open-heart surgery and
invasive cardiology (and many other mid-century heart care
innovations) resulted from the productive collaboration of
clinicians, scientists, engineers, physiologists, and individu-
als representing many other disciplines. At the same time,
huge increases in public research and health care funding
and private capital investment accelerated the pace of
invention and innovation. The collaborative model of re-
search and development was so effective that the number of
industry–academic projects and partnerships increased dra-
matically during the final third of the 20th century.
NONINVASIVE DIAGNOSIS
Meanwhile, noninvasive diagnostic techniques were intro-
duced that provided clinically useful information in many
cardiac disorders. Like so many medical-technological ad-
vances during the second half of the 20th century, echocar-
diography was a byproduct of military research. It evolved
from sonar and radar technology. Although Inge Edler and
Helmuth Hertz of Sweden published a pioneering paper on
cardiac ultrasound in 1954, the technique was not widely
used until the early 1970s. By this time, several groups had
reported its unique role in the diagnosis of pericardial
effusion and the evaluation of valve abnormalities and left
ventricular function. During the past quarter-century, clin-
ical echocardiography grew dramatically with the introduc-
tion of two-dimensional echo, Doppler and color-flow
Doppler echo, transesophageal echo, and stress echo.
Modern nuclear cardiology techniques can be traced to
Swedish physiologist Goran Liljestrand in 1939. After
1970, when the clinical potential of nuclear cardiology had
become evident, many technical and procedural innovations
led to an ever-expanding list of applications. Because the
equipment required for nuclear cardiology procedures is
larger and more expensive than echocardiography machines,
this technology has been based mainly in hospitals. More-
over, government requirements for the handling and use of
radioisotopes moderated the number of cardiologists in-
volved in nuclear cardiology procedures as compared with
echocardiography.
CORONARY CARE UNIT
AND ARRHYTHMIA MANAGEMENT
Technology drove another series of innovations that revo-
lutionized the care of cardiac patients in recent decades.
Reported between 1961 and 1963, the cardiac arrest team
and coronary care unit (CCU) concepts integrated several
technological advances that made it possible to promptly
identify and treat life-threatening cardiac arrhythmias. I will
mention just three technological factors in the cardiac care
equation. The invention of the cathode ray oscilloscope
permitted constant ECG monitoring. Temporary pacemak-
ers, developed in the 1950s, gave doctors a tool to treat
symptomatic bradyarrhythmias and heart block. The inven-
tion of the defibrillator made it possible to terminate
ventricular fibrillation, an arrhythmia that was invariably
fatal before this innovation.
Teamwork, a feature of the operating room since the late
nineteenth century, was embraced by cardiologists as tech-
nology and therapeutics were blended into new paradigms
of heart care. Special training was necessary to apply the new
diagnostic and therapeutic technologies and techniques
successfully. In the CCU, for example, specially trained
nurses were given unprecedented authority to diagnose and
treat life-threatening arrhythmias. The dramatic life-saving
potential of the CCU led to its rapid diffusion to most
community hospitals in the U.S. during the late 1960s and
1970s. As a result of this and related technological devel-
opments such as selective coronary angiography, the job
market for cardiologists grew phenomenally during the
decade.
Clinical cardiac electrophysiology (EP) is another exam-
ple of the value of interdisciplinary collaboration and the
power of the marketplace to generate capital for investment
in biomedical research and development. The origins of
clinical EP and pacing can be traced to basic EP research in
the middle of the 19th century (5). The advent of the ECG
100 years ago and the development of cardiac catheteriza-
tion techniques a half-century ago gave specialists the tools
they needed to investigate the subtleties of cardiac arrhyth-
mias in humans. Decades of research and technological
innovation paid off with the introduction of the transistor-
ized implantable cardiac pacemaker in 1960 and the devel-
opment of the automatic implantable defibrillator two
decades later.
THE FUTURE
Technology will continue to help define and direct cardiac
care for the foreseeable future. Some technological innova-
tions will be used to help doctors diagnose and treat
cardiovascular disorders, while others will facilitate basic
research aimed at preventing disease in the first place. As
new technologies and the various tests and procedures they
support are introduced into practice, physicians have a social
responsibility to use these innovations wisely. Together with
our patients and their families, doctors must become more
comfortable acknowledging that health care resources are
finite. Many things contribute to the complex equation of
health care costs in the U.S. and other countries, but
technology is an important factor. If cardiovascular special-
ists hope to have access to new, cost-effective technologies,
then we must be willing to make informed choices.
The American College of Cardiology, in partnership with
the American Heart Association and the subspecialty soci-
eties, develops guidelines to help doctors choose wisely
when it comes to technologies and procedures. Technology,
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which should supplement clinical judgment rather than
replace it, can be life enhancing and even life saving. It often
helps physicians make the correct diagnosis and initiate
optimal therapy. Although many of our current clinical
technologies are complementary, some provide redundant
information that adds nothing but cost when used to
evaluate the same problem in a single patient. The question
cardiologists should ask each time we consider ordering or
performing a test or a procedure is whether the results will
truly influence the patient’s care or outcome. If the answer
is no, then there is rarely any reason to perform it or
justification to bill for it. In the long run, everyone wins if
we use technology responsibly. The future of cardiology is
bright, and unimaginable technological innovations will
help shape and enhance that future—just as technology has
helped define the specialty as we know it today.
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